DesRosier Thomas
Transaction: 07/08/2026
BUY
Change
+7,500
Price
$9.13
Filing
07/10/2026
Type
BUY
Seres Therapeutics, Inc.
MCRB • Biotechnology
$5.72
▲ +0.08 (+1.42%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$55.17M
Growth
—
Cash Flow
1/5
Trend
Volatile
Evidence
Positive free cash flow · 0.1Healthy liquidity · 2.56Negative growth trend
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:45 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$5.72
Change1.42%
Shares Out9.64M
Market Cap$55.17M
Enterprise Value$96.22M
52W Range4.59 - 29.98
Beta0.21
P/E-2.46
P/S29.30
P/B1.60
P/FCF-1.08
EV/Sales51.10
Price$5.72
Change1.42%
Shares Out9.64M
Market Cap$55.17M
Enterprise Value$96.22M
52W Range4.59 - 29.98
Beta0.21
P/E-2.46
P/S29.30
P/B1.60
P/FCF-1.08
EV/Sales51.10
EV/EBITDA-1.92
EV/FCF-1.88
Earnings Yield-40.72%
FCF Yield-92.98%
Dividend Yield0.00%
Gross Margin-4.24%
Oper. Margin-119.10%
Profit Margin7.22%
Debt/Eq1.88
Current Ratio2.56
Quick Ratio2.56
Target$12.00
Target Upside109.79%
Target Median$12.00
Target Range12.00 - 12.00
Volume20.71K
Avg Volume86.16K
EPS Surprise-0.20
Investment DNA
How strong this company looks for long-term investors
42
out of 100
Business Quality
Margins, moat, returns
50/100
Financial Strength
Debt, cash, stability
59/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
43/100
Why this score▼
Positive free cash flow · 0.1Healthy liquidity · 2.56Negative growth trend
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 18 analyst votes · 2026-09-05
69/100
Neutral
Bullish
11
Hold
3
Bearish
4
Price Target
2026-08-07
Low
$12.00
Mean
$12.00
Median
$12.00
High
$12.00
Insider Transactions
Recent executive and insider activity
Brady Kelly
Transaction: 07/08/2026
BUY
Change
+18,750
Price
$9.13
Filing
07/10/2026
Type
BUY
Berenson Stephen
Transaction: 07/08/2026
BUY
Change
+6,500
Price
$7.14
Filing
07/10/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| DesRosier Thomas | BUY | +7,500 | $9.13 | 07/08/2026 | 07/10/2026 |
| Brady Kelly | BUY | +18,750 | $9.13 | 07/08/2026 | 07/10/2026 |
| Berenson Stephen | BUY | +6,500 | $7.14 | 07/08/2026 | 07/10/2026 |
| Rosiello Robert L. | BUY | +6,500 | $7.14 | 07/08/2026 | 07/10/2026 |
| Shaff Eric D. | BUY | +6,500 | $7.14 | 07/08/2026 | 07/10/2026 |
| Ausiello Dennis A | BUY | +6,500 | $7.14 | 07/08/2026 | 07/10/2026 |
| Dere Willard H | BUY | +6,500 | $7.14 | 07/08/2026 | 07/10/2026 |
| Fraser Claire | BUY | +6,500 | $7.14 | 07/08/2026 | 07/10/2026 |
| Thorell Marella | BUY | +7,500 | $9.13 | 07/08/2026 | 07/10/2026 |
| Henn Matthew R | BUY | +25,000 | $9.13 | 07/08/2026 | 07/10/2026 |
| Kender Richard N | BUY | +50,000 | $9.13 | 07/08/2026 | 07/10/2026 |
| Graves Kurt | BUY | +6,500 | $7.14 | 07/08/2026 | 07/10/2026 |
| Ausiello Dennis A | BUY | +7,508 | $7.94 | 07/01/2026 | 07/02/2026 |
| Rosiello Robert L. | BUY | +7,508 | $7.94 | 07/01/2026 | 07/02/2026 |
| Berenson Stephen | BUY | +7,508 | $7.94 | 07/01/2026 | 07/02/2026 |
| Henn Matthew R | SELL | -77 | $7.53 | 05/18/2026 | 05/19/2026 |
| Brady Kelly | SELL | -59 | $7.53 | 05/18/2026 | 05/19/2026 |
| DesRosier Thomas | SELL | -79 | $7.53 | 05/18/2026 | 05/19/2026 |
| Shaff Eric D. | SELL | -259 | $7.53 | 05/18/2026 | 05/19/2026 |
| Brady Kelly | SELL | -89 | Not reported | 05/15/2026 | 05/19/2026 |